688336 三生国健
2025/12 -
人民幣(K¥)

变动
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入4,199,118251.81%1,014,034825,492928,807655,006
减:营业总成本1,036,63710.79%791,663831,9221,013,410907,197
    其中:营业成本332,9539.40%224,105201,201210,020102,288
               财务费用(42,675)-16.63%(39,011)(21,970)(22,967)(9,014)
               资产减值损失488-235.93%1,064(3,612)--(15,996)
公允价值变动收益50,54974.70%19,40035,45724,20527,686
投资收益76,363-80.71%(16,399)(15,481)(3,278)(9,675)
    其中:对联营企业和合营企业的投资收益76,363-80.71%(16,399)(15,481)(3,278)(9,675)
营业利润3,326,644357.89%318,21436,944(43,630)(203,073)
利润总额3,318,538368.95%310,63428,956(53,387)(282,406)
减:所得税费用426,6822,523.77%27,274(16,479)(51,691)(46,593)
净利润2,891,855318.26%283,36045,435(1,696)(235,813)
减:非控股权益(7,450)-43.50%(11,254)(3,863)(19,755)(18,352)
股东净利润2,899,305311.49%294,61449,29718,059(217,460)

市场价值指针
每股收益 (元) *4.700312.28%0.4800.0800.030-0.370
每股派息 (元) *0.483292.68%0.050------
每股净资产 (元) *13.70551.82%7.9387.4687.3707.308
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容